U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06960694) titled 'Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis' on April 29.

Brief Summary: The purpose of this study is to evaluate the effects of L-carnitine on symptomatic improvement, oxidative stress, and inflammation in mild to moderate knee osteoarthritis patients.

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Knee Osteoarthritis

Intervention: DRUG: L-carnitine

This group will be treated with tablet L-carnitine 330 mg 3 times daily for 8 weeks and Naproxen 500 mg twice daily for the first 14 days

DRUG: Placebo

This group will be treated with tablet Placebo 330 mg 3 t...